Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis. [electronic resource]
- Journal of neurology, neurosurgery, and psychiatry Jul 2007
- 771 p. digital
Publication Type: Letter
1468-330X
10.1136/jnnp.2006.093567 doi
Adult Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Murine-Derived Antirheumatic Agents--therapeutic use Humans Male Myasthenia Gravis--drug therapy Receptor Protein-Tyrosine Kinases--analysis Receptors, Cholinergic--analysis Rituximab Treatment Outcome